Navigation Links
Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
Date:10/8/2007

BERKELEY HEIGHTS, N.J., Oct. 8 /PRNewswire/ -- Clinsys Clinical Research, Inc., a therapeutically focused clinical research organization, today announced the relocation of its corporate headquarters to accommodate the company's significant growth and plans for future expansion. The new, larger facility is located in Bedminster, New Jersey.

"Our new headquarters, combined with our recent expansion of operations in Raleigh, North Carolina and Dusseldorf, Germany, offers many advantages to Clinsys and our sponsors," said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, "The relocation strategically keeps Clinsys in the center of one of the largest biopharmaceutical clusters and experienced employee pools in the country. Our new headquarters will afford us enhanced operational performance from which to continue to provide exceptional service to our existing and new sponsors."

Clinsys will occupy the new facility on Monday, October 15. The new address is:

One Crossroads Drive, Building A, Second Floor, Bedminster, New Jersey 07921.

The new corporate telephone number is +1 908 947 7777.

The new corporate fax number is +1 908 947 7953.

About Clinsys Clinical Research, Inc.

Clinsys Clinical Research, Inc.(R), is a therapeutically focused clinical research organization and a Jubilant Organosys company, headquartered in Bedminster, New Jersey. Clinsys has operations in Raleigh, North Carolina; Philadelphia, Pennsylvania; Dusseldorf, Germany; Gent, Belgium; Noida and Bangalore, India. Clinsys provides pharmaceutical and biotechnology companies a broad range of clinical research services in support of Phase I -- IV drug development: project management, medical and clinical monitoring, investigator and patient recruitment, site management, biostatistics, data management, drug safety, quality assurance, regulatory affairs and medical writing services. Clinsys has expertise in a wide range of highly specialized therapeutic areas including oncology, cardiovascular, central nervous system, dermatology, respiratory, and allergy/immunology. Clinsys Clinical Research, Ltd., located in Noida, India, provides extensive clinical research services for Phase I -- IV drug development, and operates a clinical pharmacology unit which performs bioavailability and bioequivalence studies as well as bioanalytical sample analysis, clinical laboratory and pathology services. Targeted Clinical Staffing Solutions(R) (TCSS -- gotcss.com), a division of Clinsys Clinical Research, Inc., is a provider of professional staffing solutions and innovative partnering programs for the life sciences industry. For more information visit clinsyscro.com.

About Jubilant Organosys, Ltd.

Jubilant Organosys is an integrated pharmaceutical services provider, one of the largest custom research and manufacturing services (CRAMS), drug discovery and development services companies headquartered in India. Jubilant Organosys has more than 4,300 employees across organizations in India, the United States, Europe and China. It has four manufacturing locations in India and two in the United States. For more information visit jubl.com.

Clinsys Clinical Research and Targeted Clinical Staffing Solutions are registered trademarks of Clinsys Clinical Research, Inc.

Contact: Colin Coffua -- Vice President, Global Marketing

+1 908 464 7500

ccoffua@clinsyscro.com


'/>"/>
SOURCE Clinsys Clinical Research, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioRobot MDx standardize your automated protocols in clinical laboratories
2. What patients want: A story of choice, clinical trials & evidence-based medicine
3. ZyStor seeks to raise $15M for clinical trials
4. Prodesse begins clinical trials for flu virus detection
5. ConjuGon raises $3.3 million to fund clinical trials
6. Cancer-fighting agent heads for clinical trials
7. Quintessence cancer treatment chosen for clinical studies
8. Third Wave reports clinical growth, continued loss
9. Childrens expanding use of Sunrise Clinical Manager
10. Life-sciences conference to feature novel research with clinical potential
11. $14 million grant to drive clinical research at UW
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... portal. In response to client demand KbioBox developed a sophisticated “3 click” gene ... Both are accessible from KBioBox’s new website, https://www.kbiobox.com/ and powered ...
(Date:12/8/2016)... PRINCETON, N.J. , Dec. 8, 2016 ... late-stage biopharmaceutical company focused on developing and commercializing products ... medical need, announced today that it will be hosting ... 8:30-9:30 am ET on the origins of innate defense ... as a review of oral mucositis and the recently ...
(Date:12/8/2016)... DIEGO , Dec. 8, 2016   ... a leading commercial provider of clinically actionable liquid ... patients, announces that clinical data featuring its Target ... to tissue biopsy for the detection of actionable ... results from research sponsored by Sara Cannon Research ...
(Date:12/7/2016)... /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a biopharmaceutical company ... products for the treatment of cancer, today announced ... Development Program with Cytovance Biologics ( Oklahoma ... antibody product. Supported by recent positive interim clinical ... ovarian cancer patients, OncoQuest has engaged Cytovance to ...
Breaking Biology Technology:
(Date:11/24/2016)... IRVINE, Calif. , Nov. 23, 2016 ... help endurance athletes and their trainers non-invasively measure ... Variability Index, Pulse Rate, and Respiration Rate in approximately ... Ember enables users easy and immediate access to key ... as part of a training regimen. ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ... Banks and Academics) market is to witness a value of ... the highest Compounded Annual Growth Rate (CAGR) of 10.75% is ... analysis period 2014-2020. North America is ... Europe at 9.56% respectively. Report ...
(Date:11/14/2016)... SARASOTA, Fla., Nov. 14, 2016  xG Technology, Inc. ... in providing critical wireless communications for use in challenging ... ended September 30, 2016. Management will hold a conference ... at 5:00 p.m. Eastern Time (details below). ... announced a $16 million binding agreement to acquire Vislink ...
Breaking Biology News(10 mins):